bupropion has been researched along with modafinil in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (40.00) | 29.6817 |
| 2010's | 11 (55.00) | 24.3611 |
| 2020's | 1 (5.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Subbaiah, MAM | 1 |
| Pliszka, SR | 1 |
| Fava, M | 1 |
| Waxmonsky, JG | 1 |
| Arnsten, AF; Biederman, J; Culpepper, L; Doyle, AE; Faraone, SV; Safren, SA; Spencer, TJ; Weiss, MD; Wilens, TE | 1 |
| Baldwin, DS; Papakostas, GI | 1 |
| Ling, W; Rawson, R; Shoptaw, S | 1 |
| Kampman, KM | 1 |
| Bagot, K; Balayan, K; Davis, M; IsHak, WW; Jeffrey, J; Pechnick, RN; Rapaport, MH | 1 |
| Grabowski, J; Herin, DV; Rush, CR | 1 |
| Levin, FR; Mariani, JJ | 1 |
| Chengappa, KN; Jao, NC; Karelitz, JL; Lerman, C; Perkins, KA; Sparks, GM | 1 |
| Capellà, D; Castells, X; Farre, M; Pérez-Mañá, C; Torrens, M | 1 |
| Ancoli-Israel, S; Barsevick, AM; Berger, A; Cella, D; Fisch, M; Hinds, P; Irwin, MR; Jacobsen, P; Lai, JS; Miller, A; Mustian, K; O'Mara, A; Reeve, BB | 1 |
| Docherty, JR; Killian, LM | 1 |
| Buoli, M; Cahn, W; Serati, M | 1 |
| Bai, Z; Charach, A; Chojecki, D; Eagles, C; Elliott, J; Hossain, A; Hsieh, SC; Husereau, D; Johnston, A; Kelly, SE; Mamdani, M; Skidmore, B; Tsakonas, E; Wells, GA | 1 |
13 review(s) available for bupropion and modafinil
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Triple Reuptake Inhibitors as Potential Therapeutics for Depression and Other Disorders: Design Paradigm and Developmental Challenges.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Drug Design; Humans; Selective Serotonin Reuptake Inhibitors | 2018 |
Non-stimulant treatment of attention-deficit/hyperactivity disorder.
Topics: Adrenergic alpha-Agonists; Antidepressive Agents; Antidepressive Agents, Tricyclic; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Benzhydryl Compounds; Bupropion; Child; Clinical Trials as Topic; Humans; Modafinil; Practice Guidelines as Topic; Propylamines; Treatment Outcome | 2003 |
Daytime sleepiness and insomnia as correlates of depression.
Topics: Antidepressive Agents; Benzhydryl Compounds; Bupropion; Comorbidity; Depressive Disorder; Disorders of Excessive Somnolence; Drug Therapy, Combination; Humans; Mianserin; Mirtazapine; Modafinil; Monoamine Oxidase Inhibitors; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Sleep; Sleep Initiation and Maintenance Disorders; Trazodone | 2004 |
Nonstimulant therapies for attention-deficit hyperactivity disorder (ADHD) in children and adults.
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Behavior Therapy; Benzhydryl Compounds; Bupropion; Child; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Modafinil; Propylamines; Psychotherapy; Psychotropic Drugs | 2005 |
Symptoms of fatigue and sleepiness in major depressive disorder.
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Benzhydryl Compounds; Bupropion; Central Nervous System Stimulants; Depressive Disorder, Major; Disorders of Excessive Somnolence; Drug Therapy, Combination; Fatigue; Humans; Modafinil; Selective Serotonin Reuptake Inhibitors; Sleep Stages; Treatment Outcome | 2006 |
Management of methamphetamine abuse and dependence.
Topics: Baclofen; Benzhydryl Compounds; Brain; Bupropion; Cognition Disorders; Cognitive Behavioral Therapy; Humans; Methamphetamine; Modafinil; Nerve Net; Substance Withdrawal Syndrome; Substance-Related Disorders | 2006 |
The role of dopaminergic agents in improving quality of life in major depressive disorder.
Topics: Benzhydryl Compounds; Bupropion; Central Nervous System Stimulants; Depressive Disorder, Major; Dopamine Uptake Inhibitors; Humans; Modafinil; Quality of Life; Randomized Controlled Trials as Topic; Recurrence; Self Concept | 2009 |
Agonist-like pharmacotherapy for stimulant dependence: preclinical, human laboratory, and clinical studies.
Topics: Animals; Behavior Therapy; Benzhydryl Compounds; Bupropion; Central Nervous System Stimulants; Clinical Trials as Topic; Cognition; Dextroamphetamine; Humans; Levodopa; Methylphenidate; Modafinil; Substance-Related Disorders | 2010 |
Psychostimulant treatment of cocaine dependence.
Topics: Amphetamines; Animals; Benzhydryl Compounds; Bupropion; Central Nervous System Stimulants; Clinical Trials as Topic; Cocaine; Cocaine-Related Disorders; Combined Modality Therapy; Dopamine Agents; Humans; Methylphenidate; Modafinil; Placebos; Rats; Reinforcement, Psychology; United States | 2012 |
Efficacy of psychostimulant drugs for amphetamine abuse or dependence.
Topics: Amphetamine-Related Disorders; Benzhydryl Compounds; Bupropion; Central Nervous System Stimulants; Dextroamphetamine; Humans; Methylphenidate; Modafinil; Randomized Controlled Trials as Topic | 2013 |
Alternative pharmacological strategies for adult ADHD treatment: a systematic review.
Topics: Adrenergic alpha-Agonists; Adult; Amphetamines; Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Benzhydryl Compounds; Bridged Bicyclo Compounds, Heterocyclic; Bupropion; Central Nervous System Stimulants; Desipramine; Dopamine Agents; Droxidopa; Drug Combinations; Duloxetine Hydrochloride; Guanfacine; Histamine Agents; Humans; Lisdexamfetamine Dimesylate; Lithium Compounds; Lobeline; Mecamylamine; Memantine; Modafinil; Morpholines; Nicotinic Agonists; Nicotinic Antagonists; Nomifensine; Paroxetine; Pyridines; Pyridoxine; Pyrrolidonecarboxylic Acid; Quinazolinones; Reboxetine; Venlafaxine Hydrochloride; Wakefulness-Promoting Agents | 2016 |
Pharmacologic treatment of attention deficit hyperactivity disorder in adults: A systematic review and network meta-analysis.
Topics: Adult; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bayes Theorem; Bupropion; Central Nervous System Stimulants; Dextroamphetamine; Drug-Related Side Effects and Adverse Reactions; Female; Guanfacine; Humans; Lisdexamfetamine Dimesylate; Male; Methylphenidate; Modafinil; Network Meta-Analysis; Quality of Life; Randomized Controlled Trials as Topic | 2020 |
7 other study(ies) available for bupropion and modafinil
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
New developments in the treatment of ADHD.
Topics: Antidepressive Agents, Tricyclic; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Benzhydryl Compounds; Bupropion; Central Nervous System Stimulants; Child; Clonidine; Cognitive Behavioral Therapy; Guanfacine; Humans; Modafinil; Nicotinic Agonists; Physician's Role; Primary Health Care; Propylamines; Treatment Outcome | 2006 |
The search for medications to treat stimulant dependence.
Topics: Amphetamine-Related Disorders; Benzhydryl Compounds; Brain; Bupropion; Cocaine; Cocaine-Related Disorders; Combined Modality Therapy; Drug Approval; Humans; Methamphetamine; Modafinil; Propranolol; Psychotropic Drugs; Secondary Prevention; Substance Withdrawal Syndrome; Token Economy | 2008 |
Sensitivity and specificity of a procedure for early human screening of novel smoking cessation medications.
Topics: Adult; Benzhydryl Compounds; Bupropion; Carbon Monoxide; Cross-Over Studies; Dopamine Uptake Inhibitors; Double-Blind Method; Female; Humans; Male; Mass Screening; Middle Aged; Modafinil; Self Report; Sensitivity and Specificity; Smoking; Smoking Cessation; Time Factors; Treatment Outcome; United States; Wakefulness-Promoting Agents; Young Adult | 2013 |
Recommendations for high-priority research on cancer-related fatigue in children and adults.
Topics: Adult; Anxiety; Benzhydryl Compounds; Bupropion; Central Nervous System Stimulants; Child; Clinical Trials as Topic; Depression; Dopamine Uptake Inhibitors; Exercise; Fatigue; Female; Humans; Male; Modafinil; Motor Activity; National Cancer Institute (U.S.); Neoplasms; Patient Satisfaction; Research Design; Risk Factors; Sleep Deprivation; Treatment Outcome; United States | 2013 |
Cardiovascular stimulant actions of bupropion in comparison to cocaine in the rat.
Topics: Animals; Benzhydryl Compounds; Bupropion; Central Nervous System Stimulants; Cocaine; Desipramine; Electric Stimulation; Heart Ventricles; Hydroxamic Acids; In Vitro Techniques; Male; Modafinil; Myocardial Contraction; Nifedipine; Rats, Wistar; Vas Deferens | 2014 |